News

Developing excellence in cancer networks, a new report from the Cancer Campaigning Group (CCG), calls for the NHS Commissioning Board to establish cancer networks as Strategic Clinical Networks and recommends a series of quality markers for what cancer networks can achieve when they're working at their very best.

The Prostate Cancer Charity comments on draft guidance issued today by the National Institute for Health and Clinical Excellence (NICE), which proposes that they will not recommend abiraterone - a life extending treatment for men in the final stages of prostate cancer - to be made available on the NHS in England and Wales.